tradingkey.logo

Globus Medical Inc

GMED

55.700USD

+0.600+1.09%
終値 09/26, 16:00ET15分遅れの株価
7.52B時価総額
21.09直近12ヶ月PER

Globus Medical Inc

55.700

+0.600+1.09%
詳細情報 Globus Medical Inc 企業名
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
企業情報
企業コードGMED
会社名Globus Medical Inc
上場日Mar 08, 2012
最高経営責任者「CEO」Mr. Keith W. Pfeil
従業員数5300
証券種類Ordinary Share
決算期末Mar 08
本社所在地2560 General Armistead Ave
都市AUDUBON
証券取引所NYSE Consolidated
United States of America
郵便番号19403
電話番号16109301800
ウェブサイトhttps://www.globusmedical.com/
企業コードGMED
上場日Mar 08, 2012
最高経営責任者「CEO」Mr. Keith W. Pfeil
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
25.38K
-28.26%
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
Mr. Stephen T. (Steve) Zarrilli
Mr. Stephen T. (Steve) Zarrilli
Independent Director
Independent Director
--
--
Mr. James R. Tobin
Mr. James R. Tobin
Independent Director
Independent Director
--
--
Ms. Kelly Grace Huller, J.D.
Ms. Kelly Grace Huller, J.D.
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
--
--
Dr. John A. Deford, Ph.D.
Dr. John A. Deford, Ph.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
25.38K
-28.26%
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Musculoskeletal Solutions
575.93M
96.29%
Musculoskeletal Solutions products
575.93M
96.29%
Enabling Technologies
22.19M
3.71%
Enabling Technologies products
22.19M
3.71%
地域別USD
会社名
収益
比率
United States
483.86M
80.90%
International
114.26M
19.10%
事業別
地域別
事業別USD
会社名
収益
比率
Musculoskeletal Solutions
575.93M
96.29%
Musculoskeletal Solutions products
575.93M
96.29%
Enabling Technologies
22.19M
3.71%
Enabling Technologies products
22.19M
3.71%
株主
更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.49%
BlackRock Institutional Trust Company, N.A.
8.71%
Janus Henderson Investors
7.29%
Burgundy Asset Management Ltd.
3.09%
State Street Global Advisors (US)
3.08%
他の
68.34%
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.49%
BlackRock Institutional Trust Company, N.A.
8.71%
Janus Henderson Investors
7.29%
Burgundy Asset Management Ltd.
3.09%
State Street Global Advisors (US)
3.08%
他の
68.34%
種類
株主統計
比率
Investment Advisor
51.84%
Investment Advisor/Hedge Fund
35.76%
Hedge Fund
10.02%
Pension Fund
1.99%
Research Firm
1.43%
Sovereign Wealth Fund
1.07%
Bank and Trust
1.07%
Individual Investor
0.68%
Private Equity
0.29%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
1034
115.30M
102.09%
-12.49M
2025Q1
1057
115.54M
102.35%
-11.15M
2024Q4
1031
113.94M
83.15%
-12.71M
2024Q3
978
112.33M
98.84%
-21.04M
2024Q2
969
117.21M
103.71%
-15.66M
2024Q1
950
117.87M
104.30%
-9.50M
2023Q4
917
111.19M
96.81%
-13.25M
2023Q3
911
113.44M
96.67%
+12.22M
2023Q2
864
84.90M
108.73%
-4.84M
2023Q1
857
78.38M
100.58%
-6.61M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
10.88M
9.64%
+45.25K
+0.42%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
9.87M
8.73%
+23.63K
+0.24%
Mar 31, 2025
Janus Henderson Investors
7.01M
6.2%
+391.41K
+5.92%
Mar 31, 2025
Burgundy Asset Management Ltd.
2.80M
2.48%
+183.64K
+7.01%
Mar 31, 2025
State Street Global Advisors (US)
3.62M
3.2%
+21.05K
+0.59%
Mar 31, 2025
JP Morgan Asset Management
2.45M
2.17%
-176.33K
-6.72%
Mar 31, 2025
Sculptor Capital Management, Inc
2.09M
1.85%
+15.00K
+0.72%
Mar 31, 2025
William Blair Investment Management, LLC
2.27M
2.01%
+1.04M
+84.46%
Mar 31, 2025
Hawk Ridge Capital Management LP
1.68M
1.49%
+4.56K
+0.27%
Mar 31, 2025
Geneva Capital Management LLC
1.83M
1.62%
+17.81K
+0.98%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Sep 6
更新時刻: Sat, Sep 6
銘柄名
比率
First Trust Indxx Medical Devices ETF
1.62%
ProShares MSCI Transformational Changes ETF
0.2%
Strive 1000 Growth ETF
0.01%
AvantisUS Mid Cap Value ETF
0.01%
Vanguard US Momentum Factor ETF
0%
Vanguard S&P Mid-Cap 400 Value Index Fund
0%
Inspire Small/Mid Cap ESG ETF
0%
John Hancock Multifactor Small Cap ETF
0%
First Trust Mid Cap Core Alphadex Fund
0%
First Trust Mid Cap Value AlphaDEX Fund
0%
詳細を見る
First Trust Indxx Medical Devices ETF
比率1.62%
ProShares MSCI Transformational Changes ETF
比率0.2%
Strive 1000 Growth ETF
比率0.01%
AvantisUS Mid Cap Value ETF
比率0.01%
Vanguard US Momentum Factor ETF
比率0%
Vanguard S&P Mid-Cap 400 Value Index Fund
比率0%
Inspire Small/Mid Cap ESG ETF
比率0%
John Hancock Multifactor Small Cap ETF
比率0%
First Trust Mid Cap Core Alphadex Fund
比率0%
First Trust Mid Cap Value AlphaDEX Fund
比率0%
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI